Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
NCT04850378
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class
Conditions
Nephrotic Syndrome
Thromboembolic Disease
Interventions
DRUG:
Dalteparin
DRUG:
Apixaban
Sponsor
University of Aarhus